GLP-1 RAsGlucagon-like peptide-1 receptor agonistsdiabetesosteoarthritisOAobesitySTEP 9 trial
…Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly emerged as highly effective pharmacological tools…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,141–1,200 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Disitamab vedotin3E-cigarette3Fingolimod3Gepants3HFNC3IL-1RA3KL-63ML3853NTproBNP3Orforglipron3Rhamnose3SD2083SEC3Saxagliptin3TIGIT3TIM-33TaVNS3amphetamines3antivenom3dalteparin3eTICI 2b-33insulin glargine3interferon3isavuconazole3khat3laxatives3pazopanib3pretomanid3valacyclovir3BiPAP3Bispecific antibodies3CRP3CXCL103CXCL113Cyproheptadine3DCB3FTY7203Fecal calprotectin3Ifosfamide3Intravenous lidocaine3Losartan potassium3MG1323Macrolide3NNRTI3NOACs3OX403PAI-13PD-1 inhibitor3PSMA3PVA3SGLT2-inhibitors3Sacubitril/valsartan3TRUFILL n-BCA3Vasopressin3belimumab-treated3dronedarone3ertugliflozin3fulvestrant3gemtuzumab ozogamicin3human IL-153
Articles mentioning drugs
10,506 articles · page 379 of 876ACE inhibitorangiotensin receptor blockerβ-blockermineralocorticoid receptor antagonistheart failureClinical Practice Research DatalinkHFCVD
…ary 2009 to 31 December 2018. We evaluated non-adherence to any ACE inhibitor, angiotensin receptor blocker, β-blocker or mineralocorticoid r…
Serotoninmultiple sclerosisNeurodegeneration-Multiple Diseases
…raining dataset and 0.976 in the validation dataset.Conclusions Serotonin promotes MS progression by inhibiting ADA activity, positioning…
tirzepatidesemaglutideliraglutidetype 2 diabetes mellitusobesityHF
…fects of cagrilintide/semaglutide, liraglutide, semaglutide and tirzepatide in patients with and without a history of HF. The primary outco…
rVSVΔG-ZEBOV-GPEbola virus diseaseUniversity of BirminghamCOVID-19
…ving rVSVΔG-ZEBOV-GP with a placebo, the second group receiving rVSVΔG-ZEBOV-GP concurrently with a Pfizer–BioNTech COVID-19 booster dose. The …
sTREM-1sTREM-1-basedmalariadenguemeningitispneumoniasevere sepsisSpot Sepsis Investigator Groupseptic shocksevere febrile illness
…entifying clinical deterioration of severe sepsis compared with sTREM-1 alone (p=0.24). Sensitivity for identifying progression to seve…
90.7%
insulinASepithelial defectPEDHospital Clinico San Carlos in Madridpunctal plugsautologous serumAgencia Española del Medicamento y Productos Sanitarios
… be conducted to evaluate the efficacy and safety of the use of insulin eye-drops in the treatment of PED.Methods and analysis A presel…
tocilizumabadalimumabrheumatoid arthritisadult-onset Still’s disease (AOSD)AOSDPotassium replacement
…mmol/L) and acute flaccid paralysis after his third intravenous tocilizumab infusion. He had no prior neurological or electrolyte disturban…
Tirzepatidetype 2 diabetestype 1 diabetesT1Doverweight/obesity
…in resistance, necessitating innovative therapeutic strategies. Tirzepatide, a dual agonist for glucagon-like peptide-1 and glucose-depende…
Biosimilar medicationsmonoclonal antibodiescancersystemic inflammatory disordersneurological diseasesrheumatological diseases
…Biosimilar medications are increasingly available across neurological diseases, alongs…
eltrombopagrituximabcorticosteroidsimmune thrombocytopenic purpuraAntiphospholipid antibody syndromedigital gangrenemicrovascular coronary thrombosisAPSimmunotherapy
… immune thrombocytopenic purpura. A 32-year-old woman was given eltrombopag (a thrombopoietin receptor agonist) to treat presumed immune th…